These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10694188)

  • 1. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).
    Tang R; Hennig M; Thomasson B; Scherz R; Ravinetto R; Catalini R; Rubba P; Zanchetti A; Bond MG
    J Hypertens; 2000 Feb; 18(2):197-201. PubMed ID: 10694188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R
    J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis.
    Tang R; Hennig M; Bond MG; Hollweck R; Mancia G; Zanchetti A;
    J Hypertens; 2005 May; 23(5):1047-54. PubMed ID: 15834291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
    Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound protocol and quality control procedures in the European Lacidipine Study on Atherosclerosis (ELSA).
    Mercuri M; Tang R; Phillips RM; Bond MG
    Blood Press Suppl; 1996; 4():20-3. PubMed ID: 8973778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
    J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
    Bond MG; Mercuri M
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S11-6. PubMed ID: 8852539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A; Bond MG; Hennig M; Tang R; Hollweck R; Mancia G; Eckes L; Micheli D;
    J Hypertens; 2004 Jun; 22(6):1201-12. PubMed ID: 15167456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
    Agabiti-Rosei E; Trimarco B; Muiesan ML; Reid J; Salvetti A; Tang R; Hennig M; Baurecht H; Parati G; Mancia G; Zanchetti A;
    J Hypertens; 2005 May; 23(5):1091-8. PubMed ID: 15834297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study.
    Riley WA; Barnes RW; Applegate WB; Dempsey R; Hartwell T; Davis VG; Bond MG; Furberg CD
    Stroke; 1992 Aug; 23(8):1062-8. PubMed ID: 1636178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study.
    Paliotti R; Ciulla MM; Hennig M; Tang R; Bond MG; Mancia G; Magrini F; Zanchetti A
    J Hypertens; 2005 Jun; 23(6):1203-9. PubMed ID: 15894896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group.
    Espeland MA; Craven TE; Riley WA; Corson J; Romont A; Furberg CD
    Stroke; 1996 Mar; 27(3):480-5. PubMed ID: 8610317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA).
    Mancia G; Parati G; Hennig M; Flatau B; Omboni S; Glavina F; Costa B; Scherz R; Bond G; Zanchetti A;
    J Hypertens; 2001 Nov; 19(11):1981-9. PubMed ID: 11677363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A
    J Hypertens Suppl; 1995 Dec; 13(4):S35-9. PubMed ID: 8824685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA).
    Giannattasio C; Failla M; Hennig M; Hollweck R; Laurent S; Mallion JM; Reid J; Safar M; Bond G; Zanchetti A; Mancia G
    J Hypertens; 2005 Mar; 23(3):557-62. PubMed ID: 15716697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study.
    Chambless LE; Zhong MM; Arnett D; Folsom AR; Riley WA; Heiss G
    Ultrasound Med Biol; 1996; 22(5):545-54. PubMed ID: 8865551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries.
    Srámek A; Bosch JG; Reiber JH; Van Oostayen JA; Rosendaal FR
    Invest Radiol; 2000 Dec; 35(12):699-706. PubMed ID: 11204795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():74S-77S. PubMed ID: 8562272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint].
    Ludwig M; von Petzinger-Kruthoff A; von Buquoy M; Stumpe KO
    Ultraschall Med; 2003 Jun; 24(3):162-74. PubMed ID: 12817310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.